AORT Artivion, Inc. Common Stock
$29,85
السعر · أغسطس 19, 2026
البيانات الأساسية اعتبارًا من أغسطس 7, 2026
نطاق 52 أسبوعًا
$19–$48
37% of range
تقييم المحللين
BUY
14 analysts
السعر المستهدف
$42
+41% upside
P/E (TTM)
144.0
ROE
2.2%
هامش صافي الربح
2.2%
حول Artivion, Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
اقرأ المزيد
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.
## History
Artivion was founded as CryoLife in Sarasota, Florida in 1984 by Steven Anderson and Robert McNally. Anderson acted as the company’s president and CEO from its founding. The company later moved from Sarasota to the Atlanta metropolitan area. In January 2022 the company changed its name to Artivion, Inc.
In 2000, CryoLife began offering a surgical adhesive called BioGlue used for sealing surgical lacerations under high pressure, such as in arteries.
In February 2008, the FDA gave CryoLife approval for a new kind of heart valve, made from human tissues, which was the first to remove cells from the transplant tissue as opposed to only cleaning the tissue. In giving the approval, the FDA said the new valve, called the CryoValve SynerGraft Pulmonary Valve, had less of a chance of rejection than previous valves.
In 2010, CryoLife acquired the rights to manufacture and distribute PerClot, an absorbable hemostatic powder used in surgery.
In January 2016, the company acquired On-X Life Technologies and its principal product, a mechanical heart valve called the On-X aortic valve replacement, for $130 million.
In October 2017, Artivion acquired JOTEC GmbH, a German-based developer of medical devices for aortic and peripheral vascular diseases, for €225 million. In September 2020, the company acquired Ascyrus Medical.
In 2021, the company received FDA premarket application approval of its PerClot absorbable hemostatic system, which comprised PerClot granules and a delivery system for surgical use. Baxter International agreed to buy PerClot from Artivion in 2021. In 2023, after final FDA approval of the product, the purchase was completed.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
AORT لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$29.85
القيمة السوقية
$1.49B
P/E (TTM)
144.0
ربح السهم (آخر 12 شهرًا)
$0.21
الإيرادات (آخر 12 شهرًا)
$441M
عائد التوزيعات
—
ROE
2.2%
D/E الدين/حقوق الملكية
0.5
نطاق 52 أسبوعًا
$19 – $48
AORT مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
$441M
2016-12-31
→
2025-12-31
ربح السهم
$0.21
2016-12-31
→
2025-12-31
التدفق النقدي الحر
$839.0K
2016-12-31
→
2025-12-31
الهوامش
2.2%
2016-12-31
→
2025-12-31
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
AORT
متوسط الأقران
P/E (TTM)
144.0
38.5
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
3.4
2.5
P/B (السعر / القيمة الدفترية)
3.3
4.8
EV / EBITDA
29.2
—
Price / FCF (السعر / التدفق النقدي الحر)
1778.3
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
AORT
متوسط الأقران
Gross Margin (هامش الربح الإجمالي)
64.4%
58.7%
Operating Margin (هامش التشغيل)
7.6%
—
Net Profit Margin (هامش صافي الربح)
2.2%
-12.6%
ROA (العائد على الأصول)
1.2%
-11.8%
ROE
2.2%
-37.7%
ROIC
3.4%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
AORT
متوسط الأقران
Debt / Equity (الدين / حقوق الملكية)
0.5
25.5
Current Ratio (النسبة الحالية)
3.5
3.5
Quick Ratio (النسبة السريعة)
1.5
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
AORT
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
13.6%
—
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
12.0%
—
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
11.8%
—
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
AORT
متوسط الأقران
التوزيعات العائد، نسبة التوزيع، تاريخ توزيع الأرباح، معدل النمو السنوي المركب لمدة 5 سنوات
عائد الأرباح
—
نسبة التوزيع
—
5Y Div CAGR
—
| تاريخ الاستحقاق | المبلغ |
|---|---|
| 9 ديسمبر، 2015 | $0,0300 |
| 9 سبتمبر، 2015 | $0,0300 |
| 10 يونيو، 2015 | $0,0300 |
| 11 مارس، 2015 | $0,0300 |
| 10 ديسمبر، 2014 | $0,0300 |
| 10 سبتمبر، 2014 | $0,0300 |
| 11 يونيو، 2014 | $0,0300 |
| 12 مارس، 2014 | $0,0280 |
| 11 ديسمبر، 2013 | $0,0280 |
| 11 سبتمبر، 2013 | $0,0280 |
| 12 يونيو، 2013 | $0,0280 |
| 12 مارس، 2013 | $0,0250 |
| 12 ديسمبر، 2012 | $0,0250 |
| 12 سبتمبر، 2012 | $0,0250 |
AORT توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
14 محللين
- شراء قوي 5 35,7%
- شراء 8 57,1%
- احتفاظ 1 7,1%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
8 محللين · 2026-08-18
الوسيط
$42.00
← أقل من جميع الأهداف
$29.85
منخفض
$38.00
مرتفع
$48.00
السعر المستهدف الوسيط
$42.00
+40,7%
السعر المستهدف المتوسط
$42.15
+41,2%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
-0.02%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $-0.28 | $0.01 | -0.29% |
| 31 مارس، 2026 | $0.03 | $0.05 | -0.02% |
| 31 ديسمبر، 2025 | $0.05 | $0.08 | -0.03% |
| 30 سبتمبر، 2025 | $0.06 | $0.02 | 0.04% |
| 30 يونيو، 2025 | $0.08 | $-0.00 | 0.08% |
| 31 مارس، 2025 | $-0.01 | $-0.12 | 0.11% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| AORT | $2.25B | 217.2 | 13.6% | 2.2% | 2.2% | 64.4% |
| TNDM | $1.50B | -7.2 | 7.9% | -20.2% | -141.9% | 53.8% |
| CNMD | $1.27B | 26.9 | 5.2% | 3.4% | 4.6% | 54.6% |
| ATEC | $3.16B | -21.9 | 24.9% | -18.8% | -792.1% | 69.6% |
| ENOV | $1.52B | -1.3 | 6.7% | -52.7% | -58.5% | 59.8% |
| IART | — | -1.8 | 1.5% | -31.6% | -49.6% | — |
| KMTS | $1.21B | -8.5 | 59.0% | -138.4% | -62.1% | 51.4% |
| PRCT | $1.77B | -18.3 | 37.2% | -31.0% | -25.4% | 63.7% |
| IRMD | $1.24B | 55.6 | 14.4% | 26.8% | 23.8% | 76.8% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 18
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Cost of Revenue | $157M | $140M | $125M | $111M | $101M | $85M | $93M | $90M | $61M | $61M | $55M | $53M | |
| Gross Profit | $284M | $249M | $229M | $203M | $198M | $168M | $183M | $173M | $129M | $119M | $91M | $91M | |
| R&D Expense | $31M | $28M | $29M | $39M | $36M | $24M | $23M | $23M | $19M | $13M | $10M | $9M | |
| SG&A Expense | $226M | $181M | $209M | $157M | $170M | $141M | $143M | $141M | $101M | $92M | $75M | $74M | |
| Operating Expenses | $257M | $210M | $238M | $196M | $205M | $165M | $166M | $164M | $121M | $105M | $85M | $82M | |
| Operating Income | $34M | $39M | $6M | $6M | $8M | $2M | $17M | $9M | $8M | $22M | $5M | $9M | |
| Interest Expense | · | · | $25M | $18M | $17M | $17M | $15M | $16M | $5M | $3M | $62.0K | $175.0K | |
| Interest Income | $763.0K | $1M | $1M | $147.0K | $79.0K | $217.0K | $738.0K | $226.0K | $212.0K | $72.0K | $45.0K | $50.0K | |
| Other Non-op | $10M | $-10M | $-3M | $-3M | $-6M | $-3M | $-1M | $-141.0K | $260.0K | $-437.0K | $-484.0K | $-540.0K | |
| Pretax Income | $15M | $-8M | $-22M | $-15M | $-15M | $-17M | $2M | $-6M | $4M | $18M | $6M | $9M | |
| Income Tax | $5M | $6M | $9M | $4M | $7.0K | $-492.0K | $-76.0K | $-4M | $-143.0K | $8M | $2M | $1M | |
| Net Income | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| EPS (Basic) | $0.22 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.33 | $0.14 | $0.26 | |
| EPS (Diluted) | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 | $-0.44 | $0.05 | $-0.08 | $0.11 | $0.32 | $0.14 | $0.25 | |
| Shares (Basic) | 45,335,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,118,000 | 36,412,000 | 33,008,000 | 31,855,000 | 27,744,000 | 27,379,000 | |
| Shares (Diluted) | 47,162,000 | 41,676,000 | 40,743,000 | 40,032,000 | 38,983,000 | 37,861,000 | 37,860,000 | 36,412,000 | 34,163,000 | 32,822,000 | 28,542,000 | 28,313,000 | |
| EBITDA | $56M | $63M | $29M | $29M | $32M | $23M | $35M | $27M | $18M | $30M | · | $15M |
الميزانية العمومية 28
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $65M | $53M | $59M | $39M | $55M | $61M | $34M | $41M | $40M | $57M | $38M | $33M | |
| Receivables | $90M | $79M | $72M | $62M | $53M | $46M | $53M | $47M | $48M | $28M | $23M | $21M | |
| Inventory | $92M | $80M | $82M | $74M | $77M | $73M | $53M | $45M | $47M | $26M | $15M | $13M | |
| Prepaid Expense | $43M | $19M | $16M | $18M | $15M | $14M | $12M | $7M | $5M | $3M | $5M | $5M | |
| Current Assets | $358M | $290M | $281M | $247M | $248M | $235M | $187M | $179M | $179M | $147M | $110M | $106M | |
| PP&E (Net) | $65M | $36M | $38M | $39M | $38M | $33M | $32M | $31M | $34M | $19M | $11M | $12M | |
| PP&E (Gross) | · | · | · | $127M | $120M | $111M | $103M | $96M | $93M | $74M | $64M | $62M | |
| Accum. Depreciation | · | · | · | $88M | $82M | $78M | $71M | $65M | $60M | $55M | $53M | $50M | |
| Goodwill | $254M | $241M | $247M | $244M | $250M | $260M | $187M | $189M | $188M | $78M | $11M | $11M | |
| Intangibles | $124M | $128M | $143M | $151M | $167M | $186M | $115M | $118M | $130M | $1M | $1M | $2M | |
| Other Non-current Assets | $15M | $24M | $9M | $7M | $8M | $15M | $14M | $8M | $7M | $2M | $6M | $5M | |
| Total Assets | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Accounts Payable | $16M | $18M | $13M | $12M | $10M | $10M | $10M | $8M | $10M | $6M | $5M | $4M | |
| Accrued Liabilities | $16M | $12M | $10M | $12M | $8M | $7M | $7M | $7M | $12M | $5M | $3M | $3M | |
| Current Liabilities | $102M | $67M | $58M | $50M | $45M | $60M | $45M | $35M | $43M | $30M | $20M | $21M | |
| Capital Leases | $34M | $40M | $44M | $41M | $45M | $14M | $18M | $0 | $7M | $11.0K | · | · | |
| Deferred Tax | $24M | $20M | $22M | $24M | $29M | $35M | $26M | $27M | $30M | $7.0K | · | · | |
| Other Non-current Liabilities | $9M | $8M | $7M | $7M | $6M | $7M | $7M | $7M | $8M | $5M | $3M | $3M | |
| Total Liabilities | $437M | $513M | $511M | $478M | $492M | $461M | $320M | $296M | $313M | $107M | $26M | $27M | |
| Long-term Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Total Debt | $215M | $314M | $307M | $308M | $309M | $292M | $216M | $217M | $219M | $72M | · | · | |
| Common Stock | $493.0K | $434.0K | $426.0K | $418.0K | $414.0K | $404.0K | $390.0K | $385.0K | $376.0K | $342.0K | $298.0K | $292.0K | |
| Retained Earnings | $-51M | $-61M | $-48M | $-17M | $2M | $20M | $37M | $35M | $38M | $34M | $23M | $23M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $13M | $12M | $11M | $9M | |
| AOCI | $-3M | $-25M | $-12M | $-22M | $-10M | $7M | $-9M | $-6M | $2M | $-429.0K | $-76.0K | $-121.0K | |
| Stockholders' Equity | $448M | $276M | $282M | $284M | $301M | $329M | $286M | $275M | $277M | $209M | $155M | $149M | |
| Liabilities + Equity | $885M | $789M | $792M | $763M | $793M | $789M | $606M | $571M | $590M | $316M | $181M | $176M | |
| Shares Outstanding | 49,330,000 | 43,432,000 | 42,569,000 | 41,830,000 | 41,397,000 | 40,394,000 | 39,018,000 | 38,463,000 | 37,618,000 | 34,230,000 | 29,766,000 | 29,229,000 |
التدفق النقدي 19
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $22M | $24M | $23M | $22M | $24M | $21M | $18M | $18M | $10M | $8M | $6M | $6M | |
| Stock-based Comp | $24M | $14M | $14M | $12M | $11M | $7M | $9M | $6M | $7M | $6M | $5M | $3M | |
| Deferred Tax | $37.0K | $-2M | $-1M | $-885.0K | $-6M | $816.0K | $-2M | $-6M | $-1M | $3M | $1M | $173.0K | |
| Amort. of Intangibles | $14M | $16M | $15M | $15M | $17M | $14M | $11M | $11M | $5M | $4M | $2M | $2M | |
| Other Non-cash | $-17M | $-1M | $13M | $-20M | $-17M | $611.0K | $-11M | $-5M | $-8M | $-8M | · | $-9M | |
| Operating Cash Flow | $40M | $22M | $19M | $-5M | $-3M | $12M | $16M | $10M | $11M | $20M | $11M | $8M | |
| CapEx | $39M | $11M | $10M | $11M | $13M | $7M | $8M | $6M | $7M | $6M | $3M | $4M | |
| Investing Cash Flow | $-42M | $-28M | $-502.0K | $-11M | $6M | $-73M | $-24M | $-7M | $-171M | $-79M | $-4M | · | |
| Debt Issued | $0 | $184M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $-210.0K | $-28M | $-3M | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | $2M | $3M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Net Stock Activity | $13M | $6M | $4M | $3M | $4M | $2M | $5M | $4M | $3M | $2M | · | $-3M | |
| Dividends Paid | · | · | · | · | · | · | · | · | · | · | $3M | $3M | |
| Financing Cash Flow | $11M | $2M | $865.0K | $-2M | $-12M | $94M | $-1M | $-3M | $143M | $73M | $-3M | · | |
| Net Change in Cash | $11M | $-5M | $20M | $-16M | $-7M | $28M | $-8M | $1M | $-17M | $14M | $4M | $-4M | |
| Taxes Paid | $3M | · | · | · | · | · | · | · | · | · | $145.0K | $3M | |
| Free Cash Flow | $839.0K | $11M | $11M | $-14M | $-16M | $5M | $8M | $4M | $4M | $14M | · | $4M | |
| Levered FCF | · | · | $-25M | $-38M | $-33M | $-11M | $-8M | $-3M | $-925.8K | $12M | · | · |
الربحية 8
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% | 66.3% | 66.3% | 65.8% | 67.8% | 65.9% | · | 63.1% | |
| Operating Margin | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% | 0.96% | 6.2% | 3.5% | 4.2% | 12.1% | · | 6.1% | |
| Net Margin | 2.2% | -3.4% | -8.7% | -6.1% | -5.0% | -6.6% | 0.62% | -1.1% | 1.9% | 6.0% | · | 5.1% | |
| Pretax Margin | 3.4% | -1.9% | -6.1% | -4.8% | -5.0% | -6.8% | 0.60% | -2.4% | 1.9% | 10.2% | · | 6.0% | |
| EBITDA Margin | 12.7% | 16.2% | 8.1% | 9.1% | 10.7% | 9.1% | 12.8% | 10.4% | 9.3% | 16.7% | · | 10.3% | |
| ROA | 1.2% | -1.7% | -4.0% | -2.5% | -1.9% | -2.4% | 0.29% | -0.49% | 0.82% | 4.3% | · | 4.2% | |
| ROE | 2.2% | -4.6% | -11.1% | -7.1% | -4.9% | -5.1% | 0.61% | -1.0% | 1.5% | 5.9% | · | 5.0% | |
| ROIC | 3.4% | 11.7% | 1.4% | 1.3% | 1.3% | 0.38% | 3.6% | 0.84% | 1.7% | 4.5% | · | 5.0% |
السيولة والملاءة 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 | 3.9 | 4.1 | 5.2 | 4.2 | 4.9 | · | 5.1 | |
| Quick Ratio | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 | 1.8 | 1.9 | 2.6 | 2.0 | 2.8 | · | 2.6 | |
| Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| LT Debt / Equity | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 | 0.9 | 0.8 | 0.8 | 0.8 | 0.3 | · | · | |
| Interest Coverage | · | · | 0.2 | 0.3 | 0.5 | 0.1 | 1.1 | 0.6 | 1.6 | 7.3 | · | · |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.7 | · | 0.8 | |
| Inventory Turnover | 1.8 | 1.7 | 1.6 | 1.5 | 1.4 | 1.4 | 1.9 | 1.9 | 1.7 | 3.0 | · | 4.7 | |
| Receivables Turnover | 5.2 | 5.1 | 5.3 | 5.5 | 6.0 | 5.1 | 5.5 | 5.6 | 5.0 | 7.0 | · | 7.4 |
معدلات النمو 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.6% | 9.8% | 12.8% | 5.0% | 18.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.0% | 9.1% | 11.8% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 17
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $441M | $389M | $354M | $314M | $299M | $253M | $276M | $263M | $190M | $180M | $146M | $145M | |
| Net Income TTM | $10M | $-13M | $-31M | $-19M | $-15M | $-17M | $2M | $-3M | $4M | $11M | $4M | $7M | |
| Market Cap | $2.25B | $1.24B | $761M | $507M | $842M | $954M | $1.06B | $1.09B | $720M | $656M | · | $331M | |
| Enterprise Value | $2.40B | $1.50B | $1.01B | $776M | $1.10B | $1.18B | $1.24B | $1.27B | $899M | $670M | · | · | |
| P/E | 217.2 | -89.3 | -23.8 | -25.2 | -53.6 | -53.7 | 541.8 | -354.8 | 174.1 | 59.8 | 77.0 | 45.3 | |
| P/S | 5.1 | 3.2 | 2.2 | 1.6 | 2.8 | 3.8 | 3.8 | 4.2 | 3.8 | 3.6 | · | 2.3 | |
| P/B | 5.0 | 4.5 | 2.7 | 1.8 | 2.8 | 2.9 | 3.7 | 4.0 | 2.6 | 3.1 | · | 2.2 | |
| P / Tangible Book | 31.9 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 56.4 | 55.8 | 40.4 | -98.4 | -325.9 | 77.1 | 66.8 | 110.5 | 66.7 | 33.2 | · | 40.8 | |
| P / FCF | 2681.7 | 112.4 | 66.8 | -35.8 | -53.7 | 189.2 | 136.3 | 266.6 | 172.7 | 48.5 | · | 87.0 | |
| EV / EBITDA | 42.7 | 23.8 | 35.0 | 27.1 | 34.2 | 51.1 | 35.0 | 46.2 | 50.8 | 22.2 | · | · | |
| EV / FCF | 2860.7 | 136.0 | 88.6 | -54.7 | -70.0 | 234.9 | 159.8 | 309.4 | 215.6 | 49.6 | · | · | |
| EV / Revenue | 5.4 | 3.9 | 2.9 | 2.5 | 3.7 | 4.7 | 4.5 | 4.8 | 4.7 | 3.7 | · | · | |
| Dividend Yield | · | · | · | · | · | · | · | · | · | · | · | 0.99% | |
| Earnings Yield | 0.46% | -1.1% | -4.2% | -4.0% | -1.9% | -1.9% | 0.18% | -0.28% | 0.57% | 1.7% | 1.3% | 2.2% | |
| Payout Ratio | · | · | · | · | · | · | · | · | · | · | · | 45.0% | |
| Annual Payout | · | · | · | · | · | · | · | · | · | · | $3M | $3M |
قائمة الدخل 18
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $126M | $116M | $116M | $113M | $113M | $99M | $97M | $96M | $98M | $97M | $94M | $88M | $89M | $83M | $79M | $77M | |
| Cost of Revenue | $45M | $41M | $43M | $39M | $40M | $35M | $36M | $35M | $35M | $34M | $33M | $32M | $31M | $30M | $29M | $28M | |
| Gross Profit | $81M | $75M | $73M | $74M | $73M | $64M | $62M | $61M | $63M | $63M | $61M | $56M | $58M | $54M | $51M | $49M | |
| R&D Expense | $9M | $9M | $9M | $8M | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $6M | $7M | $7M | $8M | $12M | |
| SG&A Expense | $80M | $61M | $57M | $57M | $58M | $55M | $51M | $50M | $49M | $31M | $50M | $51M | $57M | $50M | $38M | $41M | |
| Operating Expenses | $89M | $70M | $66M | $65M | $65M | $61M | $59M | $57M | $57M | $38M | $58M | $58M | $65M | $58M | $47M | $53M | |
| Operating Income | $-8M | $6M | $11M | $13M | $8M | $2M | $3M | $4M | $7M | $25M | $3M | $-1M | $8M | $-4M | $4M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $8M | · | $7M | $6M | $6M | · | $5M | |
| Interest Income | $367.0K | $205.0K | $311.0K | $240.0K | $68.0K | $144.0K | $374.0K | $366.0K | $353.0K | $374.0K | $398.0K | $339.0K | $265.0K | $75.0K | $61.0K | $40.0K | |
| Other Non-op | $4M | $-286.0K | $1M | $399.0K | $5M | $3M | $-10M | $2M | $-983.0K | $-1M | $2M | $-2M | $-4M | $963.0K | $4M | $-4M | |
| Pretax Income | $-12M | $339.0K | $7M | $7M | $3M | $-2M | $-17M | $-1M | $-2M | $13M | $-591.0K | $-9M | $-3M | $-9M | $3M | $-13M | |
| Income Tax | $2M | $-1M | $4M | $554.0K | $2M | $-2M | $-119.0K | $1M | $-306.0K | $5M | $3M | $382.0K | $725.0K | $5M | $1M | $1M | |
| Net Income | $-14M | $1M | $2M | $7M | $1M | $-505.0K | $-16M | $-2M | $-2M | $8M | $-4M | $-10M | $-3M | $-14M | $2M | $-14M | |
| EPS (Basic) | $-0.28 | $0.03 | $0.06 | $0.14 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| EPS (Diluted) | $-0.28 | $0.03 | $0.06 | $0.13 | $0.03 | $-0.01 | $-0.40 | $-0.05 | $-0.05 | $0.18 | $-0.10 | $-0.24 | $-0.08 | $-0.33 | $0.05 | $-0.34 | |
| Shares (Basic) | 48,541,000 | 48,074,000 | -88,426,000 | 47,233,000 | 44,296,000 | 42,232,000 | -83,141,000 | 41,844,000 | 41,683,000 | 41,290,000 | -81,325,000 | 40,881,000 | 40,755,000 | 40,432,000 | -79,964,000 | 40,115,000 | |
| Shares (Diluted) | 48,541,000 | 49,731,000 | -89,223,000 | 48,775,000 | 45,378,000 | 42,232,000 | -89,737,000 | 41,844,000 | 41,683,000 | 47,886,000 | -81,325,000 | 40,881,000 | 40,755,000 | 40,432,000 | -79,964,000 | 40,115,000 | |
| EBITDA | $-8M | $12M | · | $13M | $8M | $8M | · | $4M | $7M | $31M | · | $-1M | $8M | $2M | · | $-4M |
الميزانية العمومية 26
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $77M | $56M | $65M | $73M | $53M | $38M | $53M | $56M | $55M | $51M | · | $53M | $49M | $31M | · | $38M | |
| Receivables | $98M | $92M | $90M | $88M | $91M | $88M | $79M | $76M | $74M | $74M | · | $64M | $65M | $63M | · | $57M | |
| Inventory | $103M | $98M | $92M | $91M | $87M | $82M | $80M | $84M | $81M | $82M | · | $79M | $78M | $76M | · | $73M | |
| Prepaid Expense | $27M | $45M | $43M | $22M | $25M | $20M | $19M | $19M | $20M | $17M | · | $17M | $19M | $20M | · | $17M | |
| Current Assets | $371M | $358M | $358M | $337M | $319M | $287M | $290M | $288M | $285M | $277M | · | $267M | $264M | $241M | · | $238M | |
| PP&E (Net) | $74M | $68M | $65M | $41M | $40M | $38M | $36M | $38M | $37M | $38M | · | $37M | $38M | $39M | · | $36M | |
| Goodwill | $350M | $252M | $254M | $254M | $254M | $245M | $241M | $249M | $244M | $245M | $247M | $243M | $246M | $246M | $244M | $235M | |
| Intangibles | $149M | $120M | $124M | $126M | $129M | $128M | $128M | $135M | $135M | $138M | · | $143M | $147M | $150M | · | $148M | |
| Other Non-current Assets | $15M | $16M | $15M | $29M | $27M | $25M | $24M | $21M | $14M | $13M | · | $8M | $8M | $8M | · | $7M | |
| Total Assets | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Accounts Payable | $21M | $18M | $16M | $16M | $19M | $12M | $18M | $11M | $12M | $10M | · | $11M | $10M | $9M | · | $11M | |
| Accrued Liabilities | $16M | $17M | $16M | $12M | $11M | $12M | $12M | $16M | $16M | $16M | · | $10M | $10M | $10M | · | $10M | |
| Current Liabilities | $107M | $93M | $102M | $86M | $67M | $52M | $67M | $153M | $51M | $46M | · | $55M | $56M | $44M | · | $46M | |
| Capital Leases | $36M | $34M | $34M | $38M | $39M | $39M | $40M | $41M | $42M | $43M | · | $43M | $40M | $41M | · | $41M | |
| Deferred Tax | $26M | $28M | $24M | $22M | $23M | $22M | $20M | $19M | $22M | $22M | · | $20M | $19M | $24M | · | $34M | |
| Other Non-current Liabilities | $9M | $9M | $9M | $9M | $9M | $8M | $8M | $8M | $8M | $8M | · | $8M | $7M | $7M | · | $7M | |
| Total Liabilities | $626M | $433M | $437M | $419M | $418M | $497M | $513M | $498M | $494M | $489M | · | $503M | $495M | $477M | · | $488M | |
| Long-term Debt | $363M | $215M | $215M | $215M | $216M | $315M | $314M | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Total Debt | $363M | $215M | · | $215M | $216M | $315M | · | $314M | $314M | $313M | · | $307M | $308M | $308M | · | $308M | |
| Common Stock | $502.0K | $500.0K | $493.0K | $488.0K | $486.0K | $442.0K | $434.0K | $434.0K | $433.0K | $432.0K | · | $425.0K | $424.0K | $424.0K | · | $418.0K | |
| Retained Earnings | $-64M | $-50M | $-51M | $-54M | $-60M | $-62M | $-61M | $-45M | $-42M | $-40M | · | $-44M | $-34M | $-31M | · | $-19M | |
| Treasury Stock | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | · | $15M | $15M | $15M | · | $15M | |
| AOCI | $-12M | $-12M | $-3M | $-2M | $-3M | $-19M | $-25M | $-10M | $-16M | $-14M | · | $-21M | $-16M | $-18M | · | $-45M | |
| Stockholders' Equity | $446M | $450M | $448M | $439M | $420M | $294M | $276M | $305M | $295M | $295M | $282M | $272M | $283M | $280M | $284M | $255M | |
| Liabilities + Equity | $1.07B | $883M | $885M | $858M | $838M | $791M | $789M | $803M | $790M | $784M | · | $775M | $778M | $757M | · | $743M | |
| Shares Outstanding | 50,179,000 | 49,983,000 | 49,330,000 | 48,862,000 | 48,592,000 | 44,190,000 | 43,432,000 | 43,392,000 | · | · | 42,569,000 | 42,537,000 | 42,443,000 | 42,366,000 | 41,830,000 | 41,816,000 |
التدفق النقدي 16
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $7M | $6M | $6M | $6M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $6M | |
| Stock-based Comp | $8M | $8M | $4M | $6M | $6M | $8M | $3M | $4M | $4M | $3M | $4M | $3M | $4M | $3M | $3M | $3M | |
| Deferred Tax | · | · | · | · | · | · | $3M | · | · | · | $6M | · | · | · | · | · | |
| Amort. of Intangibles | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Other Non-cash | · | $-15M | · | · | · | $-30M | · | · | · | $-22M | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-1M | $1M | $20M | $22M | $15M | $-17M | $10M | $11M | $6M | $-5M | $11M | $7M | $7M | $-6M | $-217.0K | $4M | |
| CapEx | $11M | $8M | $28M | $5M | $3M | $4M | $1M | $4M | $3M | $4M | $3M | $3M | $3M | $3M | $4M | $3M | |
| Investing Cash Flow | $-129M | $-11M | $-31M | $-5M | $-3M | $-4M | $-11M | $-11M | $-3M | $-4M | $-3M | $-2M | $7M | $-3M | $-3M | $-3M | |
| Debt Issued | · | · | $0 | $0 | $0 | $0 | $-6M | $160M | $160M | $190M | $0 | $0 | $0 | $0 | · | · | |
| Net Debt Issued | · | $0 | · | · | · | $-66.0K | · | · | · | $-182M | · | · | · | · | · | · | |
| Stock Issued | $1M | $1M | $3M | $5M | $278.0K | $4M | $443.0K | $2M | $59.0K | $4M | $488.0K | $886.0K | $0 | $3M | $24.0K | $1M | |
| Net Stock Activity | · | $1M | · | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | |
| Financing Cash Flow | $152M | $463.0K | $2M | $2M | $3M | $4M | $174.0K | $1M | $-181.0K | $737.0K | $-2M | $-909.0K | $2M | $1M | $-859.0K | $252.0K | |
| Net Change in Cash | $22M | $-9M | $-9M | $20M | $16M | $-16M | $-3M | $1M | $4M | $-8M | $5M | $5M | $18M | $-9M | $2M | $-3M | |
| Free Cash Flow | · | $-7M | · | · | · | $-21M | · | · | · | $-9M | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-14M | · | · | · | $-18M | · | · |
الربحية 8
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.0% | 64.8% | · | 65.6% | 64.7% | 64.2% | · | 63.7% | 64.6% | 64.6% | · | 64.0% | 65.1% | 64.5% | · | 63.4% | |
| Operating Margin | -6.7% | 5.0% | · | 11.1% | 7.4% | 2.2% | · | 4.6% | 6.6% | 26.0% | · | -1.4% | 8.6% | -4.6% | · | -5.3% | |
| Net Margin | -10.7% | 1.2% | · | 5.7% | 1.2% | -0.51% | · | -2.4% | -2.2% | 7.7% | · | -11.2% | -3.8% | -16.3% | · | -17.8% | |
| Pretax Margin | -9.3% | 0.29% | · | 6.2% | 3.1% | -2.3% | · | -1.3% | -2.5% | 13.1% | · | -10.7% | -3.0% | -10.7% | · | -16.3% | |
| EBITDA Margin | -6.7% | 10.4% | · | 11.1% | 7.4% | 7.7% | · | 4.6% | 6.6% | 32.0% | · | -1.4% | 8.6% | 2.2% | · | -5.3% | |
| ROA | -1.4% | 0.17% | · | 0.78% | 0.17% | -0.06% | · | -0.29% | -0.27% | 0.98% | · | -1.3% | -0.44% | -1.8% | · | -1.8% | |
| ROE | -3.1% | 0.38% | · | 1.8% | 0.38% | -0.17% | · | -0.79% | -0.73% | 2.6% | · | -3.7% | -1.2% | -4.7% | · | -4.8% | |
| ROIC | -1.2% | 3.6% | · | 1.8% | 0.51% | 0.08% | · | 1.3% | 0.93% | 2.5% | · | -0.22% | 1.7% | -1.0% | · | -0.80% |
السيولة والملاءة 5
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | 3.9 | · | 3.9 | 4.8 | 5.5 | · | 1.9 | 5.6 | 6.0 | · | 4.9 | 4.7 | 5.5 | · | 5.2 | |
| Quick Ratio | 1.6 | 1.6 | · | 1.9 | 2.2 | 2.4 | · | 0.9 | 2.5 | 2.7 | · | 2.1 | 2.0 | 2.1 | · | 2.1 | |
| Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 1.0 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| LT Debt / Equity | 0.8 | 0.5 | · | 0.5 | 0.5 | 1.1 | · | 0.7 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 3.2 | · | -0.2 | 1.2 | -0.6 | · | -0.9 |
الكفاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.5 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.4 | 1.4 | 1.2 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.4 | · | 1.4 |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $468M | $442M | · | $421M | $406M | $390M | · | $379M | $373M | $358M | · | $337M | $330M | $318M | · | $307M | |
| Net Income TTM | $-4M | $9M | · | $5M | $-4M | $3M | · | $-7M | $-8M | $-19M | · | $-40M | $-35M | $-35M | · | $-11M | |
| Market Cap | $1.13B | $1.83B | · | $2.07B | $1.51B | $1.09B | · | $1.16B | · | · | · | $645M | $730M | $555M | · | $579M | |
| Enterprise Value | $1.41B | $1.99B | · | $2.21B | $1.67B | $1.36B | · | $1.41B | · | · | · | $899M | $988M | $832M | · | $849M | |
| P/E | -249.7 | 203.4 | · | 423.4 | -388.8 | 351.1 | · | -166.4 | -135.0 | -45.0 | · | -15.3 | -20.0 | -15.2 | · | -51.3 | |
| P/S | 2.4 | 4.1 | · | 4.9 | 3.7 | 2.8 | · | 3.0 | · | · | · | 1.9 | 2.2 | 1.7 | · | 1.9 | |
| P/B | 2.5 | 4.1 | · | 4.7 | 3.6 | 3.7 | · | 3.8 | · | · | · | 2.4 | 2.6 | 2.0 | · | 2.3 | |
| P / Tangible Book | · | 23.2 | · | 35.5 | 41.0 | · | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | 1586.1 | · | · | · | -64.1 | · | · | · | · | · | · | · | -90.2 | · | · | |
| P / FCF | · | -267.2 | · | · | · | -52.8 | · | · | · | · | · | · | · | -66.1 | · | · | |
| EV / EBITDA | -169.0 | 164.1 | · | 176.3 | 199.6 | 179.6 | · | 322.1 | · | · | · | -722.5 | 128.8 | 444.3 | · | -206.9 | |
| EV / FCF | · | -290.5 | · | · | · | -66.2 | · | · | · | · | · | · | · | -99.2 | · | · | |
| EV / Revenue | 3.0 | 4.5 | · | 5.2 | 4.1 | 3.5 | · | 3.7 | · | · | · | 2.7 | 3.0 | 2.6 | · | 2.8 | |
| Earnings Yield | -0.40% | 0.49% | · | 0.24% | -0.26% | 0.28% | · | -0.60% | -0.74% | -2.2% | · | -6.5% | -5.0% | -6.6% | · | -1.9% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $441M | $389M | $354M | $314M | $299M |
| هامش الربح الإجمالي % | 64.4% | 64.0% | 64.7% | 64.5% | 66.1% |
| هامش الربح التشغيلي % | 7.6% | 10.0% | 1.6% | 2.0% | 2.7% |
| صافي الدخل | $10M | $-13M | $-31M | $-19M | $-15M |
| EPS المخفف | $0.21 | $-0.32 | $-0.75 | $-0.48 | $-0.38 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.5 | 1.1 | 1.1 | 1.1 | 1.0 |
| النسبة الحالية | 3.5 | 4.3 | 4.9 | 5.0 | 5.5 |
| النسبة السريعة | 1.5 | 2.0 | 2.3 | 2.0 | 2.4 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $839.0K | $11M | $11M | $-14M | $-16M |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 217 مقدمي إقرار · $728.9M إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 42 (+7 مقابل الربع السابق) | 64 (+28 مقابل الربع السابق) | 80 (-7 مقابل الربع السابق) | 47 (-16 مقابل الربع السابق) | +5.4M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $71566000 | 3184974 | 9,82% | الأسهم |
| Juniper Investment Company, LLC | $45386816 | 2019885 | 6,23% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $45043789 | 2004619 | 6,18% | الأسهم |
| FMR LLC | $41871497 | 1863440 | 5,74% | الأسهم |
| STATE STREET CORP | $41750406 | 1858051 | 5,73% | الأسهم |
| Ophir Asset Management Pty Ltd | $40446180 | 1800008 | 5,55% | الأسهم |
| PERCEPTIVE ADVISORS LLC | $39036906 | 1737290 | 5,36% | الأسهم |
| Conestoga Capital Advisors, LLC | $36484539 | 1623700 | 5,01% | الأسهم |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $23011325 | 1024091 | 3,16% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $22205281 | 988219 | 3,05% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $21427261 | 953365 | 2,94% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $20062856 | 892873 | 2,75% | الأسهم |
| CITADEL ADVISORS LLC | $17701821 | 787798 | 2,43% | الأسهم |
| YARGER WEALTH STRATEGIES, LLC | $15278432 | 634223 | 2,10% | الأسهم |
| ROYCE & ASSOCIATES LP | $14364667 | 639282 | 1,97% | الأسهم |
| WELLINGTON MANAGEMENT GROUP LLP | $11702264 | 520795 | 1,61% | الأسهم |
| Qube Research & Technologies Ltd | $10704820 | 476405 | 1,47% | الأسهم |
| FRED ALGER MANAGEMENT, LLC | $10406104 | 463111 | 1,43% | الأسهم |
| TWO SIGMA ADVISERS, LP | $9974907 | 218700 | 1,37% | الأسهم |
| D. E. Shaw & Co., Inc. | $9846714 | 438216 | 1,35% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9183579 | 408704 | 1,26% | الأسهم |
| Toroso Investments, LLC | $9018146 | 197723 | 1,24% | الأسهم |
| Soleus Capital Management, L.P. | $8718360 | 388000 | 1,20% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $8702159 | 387279 | 1,19% | الأسهم |
| Balyasny Asset Management L.P. | $8584686 | 382051 | 1,18% | الأسهم |
| GOLDMAN SACHS GROUP INC | $7733095 | 344152 | 1,06% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $6978103 | 310552 | 0,96% | الأسهم |
| KENNEDY CAPITAL MANAGEMENT LLC | $6611371 | 294231 | 0,91% | الأسهم |
| UBS Group AG | $6026544 | 268204 | 0,83% | الأسهم |
| WASATCH ADVISORS LP | $5726929 | 156388 | 0,79% | الأسهم |
| BRIDGER MANAGEMENT, LLC | $4855373 | 132588 | 0,67% | الأسهم |
| Quantinno Capital Management LP | $4497191 | 200142 | 0,62% | الأسهم |
| AMERIPRISE FINANCIAL INC | $4347068 | 193461 | 0,60% | الأسهم |
| FIFTH THIRD BANCORP | $4170912 | 185621 | 0,57% | الأسهم |
| ORBIMED ADVISORS LLC | $3932250 | 175000 | 0,54% | الأسهم |
| Corient Private Wealth LP | $3578618 | 159262 | 0,49% | الأسهم |
| Public Sector Pension Investment Board | $3298304 | 146787 | 0,45% | الأسهم |
| Parkman Healthcare Partners LLC | $3121982 | 138940 | 0,43% | الأسهم |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $2879149 | 128133 | 0,40% | الأسهم |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $2857263 | 127159 | 0,39% | الأسهم |
| Summit Creek Advisors LLC | $2704354 | 120354 | 0,37% | الأسهم |
| CONNORS INVESTOR SERVICES INC | $2700445 | 120180 | 0,37% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $2693816 | 119885 | 0,37% | الأسهم |
| Bank of New York Mellon Corp | $2522415 | 112257 | 0,35% | الأسهم |
| RHUMBLINE ADVISERS | $2373280 | 105621 | 0,33% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2303872 | 102531 | 0,32% | الأسهم |
| XTX Topco Ltd | $2173905 | 96747 | 0,30% | الأسهم |
| Swiss National Bank | $1914444 | 85200 | 0,26% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $1912535 | 85115 | 0,26% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1875420 | 51213 | 0,26% | الأسهم |
| LAZARD ASSET MANAGEMENT LLC | $1875301 | 83458 | 0,26% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $1524073 | 67827 | 0,21% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $1522477 | 41575 | 0,21% | الأسهم |
| Legal & General Group Plc | $1468954 | 65374 | 0,20% | الأسهم |
| CITIGROUP INC | $1425856 | 63456 | 0,20% | الأسهم |
| Squarepoint Ops LLC | $1424238 | 63384 | 0,20% | الأسهم |
| Russell Investments Group, Ltd. | $1303125 | 57994 | 0,18% | الأسهم |
| VICTORY CAPITAL MANAGEMENT INC | $1193157 | 53100 | 0,16% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $1117972 | 49754 | 0,15% | الأسهم |
| Sterling Capital Management LLC | $1098918 | 48906 | 0,15% | الأسهم |
| Sio Capital Management, LLC | $1089368 | 48481 | 0,15% | الأسهم |
| BOOTHBAY FUND MANAGEMENT, LLC | $1010521 | 44972 | 0,14% | الأسهم |
| PRUDENTIAL FINANCIAL INC | $995219 | 44291 | 0,14% | الأسهم |
| WELLS FARGO & COMPANY/MN | $937314 | 41714 | 0,13% | الأسهم |
| VANGUARD GROUP INC | $898699 | 19704 | 0,12% | الأسهم |
| FIRST TRUST ADVISORS LP | $857657 | 38169 | 0,12% | الأسهم |
| BlackRock, Inc. | $789461 | 35134 | 0,11% | الأسهم |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $738274 | 32856 | 0,10% | الأسهم |
| Verition Fund Management LLC | $729399 | 32461 | 0,10% | الأسهم |
| Aquatic Capital Management LLC | $712771 | 31721 | 0,10% | الأسهم |
| Jain Global LLC | $680908 | 30303 | 0,09% | الأسهم |
| JONES FINANCIAL COMPANIES LLLP | $662072 | 28042 | 0,09% | الأسهم |
| Brevan Howard Capital Management LP | $652461 | 29037 | 0,09% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $634193 | 28224 | 0,09% | الأسهم |
| JANUS HENDERSON GROUP PLC | $623335 | 17038 | 0,09% | الأسهم |
| MetLife Investment Management, LLC | $601050 | 26749 | 0,08% | الأسهم |
| Y-Intercept (Hong Kong) Ltd | $600735 | 26735 | 0,08% | الأسهم |
| Mariner, LLC | $570520 | 25390 | 0,08% | الأسهم |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $561750 | 25000 | 0,08% | الأسهم |
| Illinois Municipal Retirement Fund | $545010 | 24255 | 0,07% | الأسهم |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $516855 | 23002 | 0,07% | الأسهم |
| Walleye Capital LLC | $490408 | 21825 | 0,07% | الأسهم |
| Penn Capital Management Company, LLC | $489689 | 21793 | 0,07% | الأسهم |
| ALLSTATE CORP | $483240 | 21506 | 0,07% | الأسهم |
| EXCHANGE TRADED CONCEPTS, LLC | $476948 | 21226 | 0,07% | الأسهم |
| MORGAN STANLEY | $476588 | 21210 | 0,07% | الأسهم |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $473241 | 21061 | 0,06% | الأسهم |
| Louisiana State Employees Retirement System | $420189 | 18700 | 0,06% | الأسهم |
| Invesco Ltd. | $409628 | 18230 | 0,06% | الأسهم |
| DARK FOREST CAPITAL MANAGEMENT LP | $402123 | 17896 | 0,06% | الأسهم |
| Vanguard Global Advisers, LLC | $371384 | 16528 | 0,05% | الأسهم |
| Freestone Grove Partners LP | $328219 | 14607 | 0,05% | الأسهم |
| NEW YORK STATE COMMON RETIREMENT FUND | $324287 | 14432 | 0,04% | الأسهم |
| JOHNSON INVESTMENT COUNSEL INC | $307008 | 13663 | 0,04% | الأسهم |
| Police & Firemen's Retirement System of New Jersey | $303053 | 13487 | 0,04% | الأسهم |
| DIKER MANAGEMENT LLC | $303000 | 13500 | 0,04% | الأسهم |
| OPPENHEIMER ASSET MANAGEMENT INC. | $284672 | 12669 | 0,04% | الأسهم |
| GUGGENHEIM CAPITAL LLC | $283302 | 12608 | 0,04% | الأسهم |
| ELEVATION POINT WEALTH PARTNERS, LLC | $263303 | 11718 | 0,04% | الأسهم |
| Vestmark Advisory Solutions, Inc. | $263303 | 11718 | 0,04% | الأسهم |
المطلعون على الشركة 49 من المطلعين · مسؤولون 27 · مديرون 15
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| James P Mackin | President & CEO | 6 مارس، 2025 M | 865283 | 0 | 0 | $0 |
| David Ashley Lee | Executive VP, COO & CFO | 2 مارس، 2023 S | 347217 | 0 | 0 | $0 |
| Marshall S. Stanton | SVP, Clinical & MD Affair | 17 يونيو، 2025 S | 64200 | 0 | 0 | $0 |
| John E Davis | Chief Commercial Officer | 11 مارس، 2025 M | 208778 | 0 | 0 | $0 |
| Amy Horton | VP, Chief Accounting Officer | 6 مارس، 2025 S | 146651 | 0 | 0 | $0 |
| Matthew A Getz | VP, Human Resources | 16 أغسطس، 2024 S | 34116 | 0 | 0 | $0 |
| Florian Tyrs | VP, Global Operations | 27 فبراير، 2024 S | 21558 | 0 | 0 | $0 |
| Rochelle L. Maney | VP, Quality | 26 فبراير، 2024 S | 44518 | 0 | 0 | $0 |
| Robert C Thomson | VP Research & Development | 23 فبراير، 2024 A | 13291 | 0 | 0 | $0 |
| Dennis B Maier | SVP, Operations | 6 يونيو، 2023 S | 34724 | 0 | 0 | $0 |
| Franz Peter Barthold | VP, Research & Development | 8 نوفمبر، 2022 A | 32516 | 0 | 0 | $0 |
| Scott B Capps | VP, Clinical Research | 12 مارس، 2021 F | 153203 | 0 | 0 | $0 |
| James M Mcdermid | SVP, CHRO | 14 مارس، 2019 F | 30806 | 0 | 0 | $0 |
| Sherry M Saurini | VP, Quality | 14 مارس، 2019 F | 25084 | 0 | 0 | $0 |
| William Robert Matthews | Senior VP, Operations, Quality | 5 مارس، 2018 F | 39883 | 0 | 0 | $0 |
| David C Gale | VP, Research & Development | 16 نوفمبر، 2017 M | 77135 | 0 | 0 | $0 |
| Steven G Anderson | Former Executive Chairman | 9 إبريل، 2015 F | 1271846 | 0 | 0 | $0 |
| Bruce G. Anderson | VP, US Sales &Global Marketing | 7 مارس، 2015 F | 42106 | 0 | 0 | $0 |
| FRONK DAVID | VP, Regulatory Affairs | 7 مارس، 2015 F | 110559 | 0 | 0 | $0 |
| David P. Lang | VP, Int'l Sales & Marketing | 26 فبراير، 2015 A | 73441 | 0 | 0 | $0 |
| Jeffrey W Burris | Vice President & Gen. Counsel | 15 أغسطس، 2014 M | 95221 | 0 | 0 | $0 |
| Gerald B Seery | Sr. VP, Sales and Marketing | 30 نوفمبر، 2012 S | 71999 | 0 | 0 | $0 |
| Albert E Heacox | Sr. VP Research and Devl | 31 ديسمبر، 2011 F | 110144 | 0 | 0 | $0 |
| Philip A Theodore | VP, General Counsel | 4 سبتمبر، 2007 A | 23100 | 0 | 0 | $0 |
| Sidney B Ashmore | Vice President of Marketing | 18 يناير، 2006 M | 42728 | 0 | 0 | $0 |
| Kirby S Black | Sr. Vice President, R&D | 21 سبتمبر، 2004 M | 55131 | 0 | 0 | $0 |
| Vander James C Wyk | VP - Product Integrity | 14 سبتمبر، 2004 M | 36165 | 0 | 0 | $0 |
| Anthony B. Semedo | مدير | 2 يونيو، 2026 J | 6325 | 0 | 0 | $0 |
| Elizabeth A Hoff | مدير | 22 مايو، 2025 A | 31389 | 0 | 0 | $0 |
| Marna P Borgstrom | مدير | 22 مايو، 2025 A | 49088 | 0 | 0 | $0 |
| Jon W Salveson | مدير | 22 مايو، 2025 A | 129840 | 0 | 0 | $0 |
| Jeffrey H Burbank | مدير | 22 مايو، 2025 A | 53796 | 0 | 0 | $0 |
| Daniel J Bevevino | مدير | 22 مايو، 2025 A | 150061 | 0 | 0 | $0 |
| Bullock James | مدير | 22 مايو، 2025 A | 68647 | 0 | 0 | $0 |
| Thomas F Ackerman | مدير | 22 مايو، 2025 A | 149896 | 0 | 0 | $0 |
| Harvey Morgan | مدير | 30 أغسطس، 2021 G | 46342 | 0 | 0 | $0 |
| Ronald D Mccall | مدير | 25 أغسطس، 2021 S | 121768 | 0 | 0 | $0 |
| Elkins C Ronald | مدير | 5 سبتمبر، 2018 S | 64843 | 0 | 0 | $0 |
| James Benson | مدير | 2 أكتوبر، 2017 S | 54086 | 0 | 0 | $0 |
| John M Cook | مدير | 9 يونيو، 2009 M | 85000 | 0 | 0 | $0 |
| LACY VIRGINIA C | مدير | 24 إبريل، 2007 S | 255280 | 0 | 0 | $0 |
| VAN DYNE BRUCE J MD | مدير | 1 أغسطس، 2006 A | 12800 | 0 | 0 | $0 |
| OSS CAPITAL MANAGEMENT | مالك 10% | 31 مايو، 2007 S | 1918000 | 0 | 0 | $0 |
| Lance A Berry | — | 14 أغسطس، 2026 S | 210112 | 0 | 1 | $-20413 |
| Andrew M Green | — | 14 أغسطس، 2026 S | 59643 | 0 | 3 | $-928248 |
| Jean F Holloway | — | 12 أغسطس، 2026 S | 184118 | 0 | 1 | $-27835 |
| Michael S Simpson | — | 5 مارس، 2021 F | 33698 | 0 | 0 | $0 |
| Thomas J Bogenschuetz | — | 5 مايو، 2020 A | 23451 | 0 | 0 | $0 |
| Thomas J Lynch | — | 2 نوفمبر، 2004 A | 5000 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 5 حيازات
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Juniper Targeted Opportunity Fund, L.P., Juniper HF Investors II, LLC, Juniper Targeted Opportunities, L.P., Juniper Targeted Opportunity Investors, LLC, Juniper Multi-Strategy Fund, L.P., Juniper HF Investors, LLC, Juniper Investment Company, LLC, Alexis P. Michas, John A. Bartholdson ×2 إيداعات | 12 أغسطس، 2025 | 4,00% | تعديل | — | SEC |
| CryoLife, Inc., CL Falcon, Inc. | 11 مايو، 2011 | — | إيداع أولي | اندماج واستحواذ / بيع | SEC |
| Michael A. Roth and Brian J. Stark, as joint filers pursuant to Rule 13d-1(k) | 10 يوليو، 2007 | — | إيداع أولي | — | SEC |
| شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه, شخص مُبلِّغ لم يُكشف عنه | 2 ديسمبر، 2005 | — | إيداع أولي | استثمار سلبي | SEC |
| شخص مُبلِّغ لم يُكشف عنه | 18 مارس، 2005 | — | إيداع أولي | استثمار سلبي | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 53 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| SAWS · ETF Series Solutions | 2,95% | 5817 NS | 30 إبريل، 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,77% | 26421 NS | 30 إبريل، 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 0,59% | 37075 SH | 8 أغسطس، 2026 | يومي |
| RZG · Invesco Exchange-Traded Fund Trust | 0,44% | 22725 SH | 8 أغسطس، 2026 | يومي |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,25% | 21547 NS | 31 مايو، 2026 | N-PORT |
| ESSC · Strategy Shares | 0,24% | 1691 NS | 30 إبريل، 2026 | N-PORT |
| XSMO · Invesco Exchange-Traded Fund Trust | 0,21% | 246008 SH | 8 أغسطس، 2026 | يومي |
| IHI · iShares Trust | 0,16% | 202161 SH | 8 أغسطس، 2026 | يومي |
| IJT · iShares Trust | 0,13% | 397869 SH | 8 أغسطس، 2026 | يومي |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,11% | 31285 NS | 30 إبريل، 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,10% | 50848 SH | 8 أغسطس، 2026 | يومي |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,08% | 7285 SH | 8 أغسطس، 2026 | يومي |
| IWO · iShares Trust | 0,08% | 419028 SH | 8 أغسطس، 2026 | يومي |
| XJR · iShares Trust | 0,07% | 5059 SH | 8 أغسطس، 2026 | يومي |
| IJR · iShares Trust | 0,06% | 2606468 SH | 8 أغسطس، 2026 | يومي |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 49054 SH | 8 أغسطس، 2026 | يومي |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,05% | 148966 SH | 8 أغسطس، 2026 | يومي |
| RSSL · Global X Funds | 0,05% | 18968 NS | 30 إبريل، 2026 | N-PORT |
| SAA · ProShares Trust | 0,04% | 505 NS | 31 مايو، 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,04% | 158121 NS | 30 إبريل، 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 1162604 SH | 8 أغسطس، 2026 | يومي |
| ISCG · iShares Trust | 0,04% | 14407 SH | 8 أغسطس، 2026 | يومي |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,04% | 28917 SH | 8 أغسطس، 2026 | يومي |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 14525 NS | 31 مايو، 2026 | N-PORT |
| EBIT · Harbor ETF Trust | 0,03% | 101 NS | 30 إبريل، 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 263046 SH | 8 أغسطس، 2026 | يومي |
| SMDX · Tidal Trust III | 0,03% | 999 NS | 30 إبريل، 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 27103 SH | 8 أغسطس، 2026 | يومي |
| ITWO · ProShares Trust | 0,02% | 2057 NS | 31 مايو، 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 18392 NS | 30 إبريل، 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,02% | 2917 NS | 30 إبريل، 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,02% | 200917 NS | 31 مايو، 2026 | N-PORT |
| ISCB · iShares Trust | 0,02% | 2111 SH | 8 أغسطس، 2026 | يومي |
| UWM · ProShares Trust | 0,01% | 1609 NS | 31 مايو، 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 1624 NS | 31 مايو، 2026 | N-PORT |
| JSTC · Tidal Trust I | 0,01% | 1526 NS | 31 مايو، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 495296 SH | 8 أغسطس، 2026 | يومي |
| VHT · VANGUARD WORLD FUND | 0,01% | 127662 SH | 8 أغسطس، 2026 | يومي |
| WSML · iShares Trust | 0,01% | 2264 SH | 8 أغسطس، 2026 | يومي |
| DFAC · Dimensional ETF Trust | 0,01% | 107410 NS | 30 إبريل، 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1773 NS | 31 مايو، 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 3861 NS | 30 إبريل، 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 41 NS | 31 مايو، 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 1937 NS | 30 إبريل، 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 8873 NS | 30 إبريل، 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 12377 NS | 30 إبريل، 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 61883 SH | 8 أغسطس، 2026 | يومي |
| IWV · iShares Trust | 0,00% | 10738 SH | 8 أغسطس، 2026 | يومي |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 25635 NS | 31 مايو، 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 636 NS | 30 إبريل، 2026 | N-PORT |